Clinical Trial Update: Low Dose Growth Hormone in Obese PCOS Women [NA]

View source ↗

Summary

This document reports that a clinical trial testing low-dose growth hormone in obese women with polycystic ovary syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Polycystic Ovary Syndrome | NA | Status: WITHDRAWN